Skip to main content

Gene Therapy

Vector Technology and Clinical Applications

  • Chapter
Molecular Genetic Pathology
  • 2060 Accesses

Abstract

Gene therapy can be defined as the transfer of genetic material with therapeutic intent. Gene transfer has become clinically feasible as our understanding of the molecular basis of disease has matured and we have developed improved techniques for manipulating genetic material

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

General

  • Cornetta K, Matheson L, Ballas C. Retroviral vector production in the National Gene Vector Laboratory at Indiana University. Gene Ther. 2005;12:S28–S35.

    Article  CAS  PubMed  Google Scholar 

  • Frampton A Jr, Goins W, Nakano K, Burton E, Glorioso J. HSV trafficking and development of gene therapy vectors with applications in the nervous system. Gene Ther. 2005;12:891–901.

    Article  CAS  PubMed  Google Scholar 

  • McConnell MJ, Imperialge MJ. Biology of adenovirus and its use as a vector for gene therapy. Hum Gene Ther. 2004;15:1022–1033.

    Article  CAS  PubMed  Google Scholar 

  • Muzyczka N, Warrington KH Jr. Custom adeno-associated virus capsids: The next generation of recombinant vectors with novel tropism. Hum Gene Ther. 2005;16:408–416.

    Article  CAS  PubMed  Google Scholar 

  • Parekh-Olmedo H, Ferrara L, Brachman E, Kmiec EB. Gene therapy progress and prospects: targeted gene repair. Gene Ther. 2005;12:639–646.

    Article  CAS  PubMed  Google Scholar 

  • Polak J, Hench L. Gene therapy progress and prospects: In tissue engineering. Gene Ther. 2005;12:1725–1733.

    Article  CAS  PubMed  Google Scholar 

  • Sinn PL, Sauter SL, McCray PB Jr. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors-design, biosafety, and production. Gene Ther. 2005;12:1089–1098.

    Article  CAS  PubMed  Google Scholar 

  • Verma IM, Weitzman MD. Gene therapy: twenty-first century medicine. Annual Rev Biochem. 2005;74:711–738.

    Article  CAS  Google Scholar 

Non-Viral Gene Transfer

  • Gleave M, Monia B. Antisense therapy for cancer. Nat Rev Cancer. 2005;5:468–479.

    Article  CAS  PubMed  Google Scholar 

  • Glover D, Lipps H, Jans D. Towards safe, non-viral therapeutic gene expression in humans. Nat Rev Genet. 2005;6:299–310.

    Article  CAS  PubMed  Google Scholar 

  • Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990;257:1465–1468.

    Article  Google Scholar 

Clinical Studies—Classic Papers and Recent Reviews

  • Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002;296:2410–2413.

    Article  CAS  PubMed  Google Scholar 

  • Blaese RM, Culver KW, Miller AD, et al. T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 1995;270:475–480.

    Article  CAS  PubMed  Google Scholar 

  • Brenner MK, Rill DR, Moen RC, et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993;341:85–86.

    Article  CAS  PubMed  Google Scholar 

  • Carter B. Adeno-associated virus vectors in clinical trials. Hum Gene Ther. 2005;16:541–550.

    Article  CAS  PubMed  Google Scholar 

  • Cornetta K, Smith FO. Regulatory issues for clinical gene therapy trials. Hum Gene Ther. 2002;13:1143–1149.

    Article  CAS  PubMed  Google Scholar 

  • Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med. 2002;346:1185–1193.

    Article  CAS  PubMed  Google Scholar 

  • Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2004;348:255, 256.

    Article  Google Scholar 

  • Nathwani A, Davidoff A, Linch D. A review of gene therapy for haematological disorders. Br J Haematol. 2004;128:3–17.

    Article  CAS  Google Scholar 

  • Peng Z. Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum Gene Ther. 2005;16:1016–1027.

    Article  CAS  PubMed  Google Scholar 

  • Rosenberg SA, Aebersold P, Cornetta K, et al. Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med. 1990;323:570–578.

    Article  CAS  PubMed  Google Scholar 

  • Strayer D, Akkina R, Bunnell B, et al. Current status of gene therapy strategies to treat HIV/AIDS. Mol Ther. 2005;11(6):823–842.

    Article  CAS  PubMed  Google Scholar 

Cancer Gene Therapy

  • Abonour R, Williams DA, Einhorn E, et al. Efficient retroviral-mediated MDR-1 gene transfer into autologous human long-term repopulating hematopoietic stem cells. Nat Med. 2000;6:652–658

    Article  CAS  PubMed  Google Scholar 

  • Aghi M, Martuza R. Oncolytic viral therapies-the clinical experience. Oncogene 2005;24:7802–7816.

    Article  CAS  PubMed  Google Scholar 

  • Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony stimulating factor stimulates potent, long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993;90:3539–3543.

    Article  CAS  PubMed  Google Scholar 

  • Gallo P, Dharmapuri S, Cipriani B, Monaci P. Adenovirus as vehicle for anticancer genetic immunotherapy. Gene Ther. 2005;12:S84–S91.

    Article  CAS  PubMed  Google Scholar 

  • Kershaw M, Teng M, Smyth M, Darcy P. Supernatural T cells: genetic modification of T cells for cancer therapy. Nat Rev Immunol. 2005;5:928–940.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Cornetta, K. (2008). Gene Therapy. In: Cheng, L., Zhang, D.Y. (eds) Molecular Genetic Pathology. Humana Press. https://doi.org/10.1007/978-1-59745-405-6_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-405-6_29

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-974-1

  • Online ISBN: 978-1-59745-405-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics